139 related articles for article (PubMed ID: 27564105)
21. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
[TBL] [Abstract][Full Text] [Related]
22. D-dimer Level Changes During Systemic Chemotherapy Can Predict Prognosis of High-grade Musculoskeletal Sarcoma Patients.
Morii T; Tajima T; Aoyagi T; Ichimura S
Anticancer Res; 2015 Dec; 35(12):6781-6. PubMed ID: 26637896
[TBL] [Abstract][Full Text] [Related]
23. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
[TBL] [Abstract][Full Text] [Related]
24. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis.
Lin Y; Liu Z; Qiu Y; Zhang J; Wu H; Liang R; Chen G; Qin G; Li Y; Zou D
Eur J Surg Oncol; 2018 Oct; 44(10):1494-1503. PubMed ID: 30100361
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL).
Liu B; Li B; Zhou P; Yue W; Wang T; Wang J; Hu X; Zhang W; Chen J; Chen L; Gao L; He M; Yang J
Clin Chim Acta; 2018 Jul; 482():191-198. PubMed ID: 29649456
[TBL] [Abstract][Full Text] [Related]
28. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma.
Duffaud F; Egerer G; Ferrari S; Rassam H; Boecker U; Bui-Nguyen B
Eur J Cancer; 2012 Mar; 48(4):564-70. PubMed ID: 22243773
[TBL] [Abstract][Full Text] [Related]
31. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.
Flores RJ; Kelly AJ; Li Y; Chen X; McGee C; Krailo M; Barkauskas DA; Hicks J; Man TK
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544777
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
Qu JT; Wang M; He HL; Tang Y; Ye XJ
J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
[TBL] [Abstract][Full Text] [Related]
34. D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma.
Morii T; Mochizuki K; Tajima T; Ichimura S; Satomi K
BMC Musculoskelet Disord; 2011 Nov; 12():250. PubMed ID: 22044610
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
36. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
37. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
Kim W; Han I; Lee JS; Cho HS; Park JW; Kim HS
J Surg Oncol; 2018 May; 117(6):1223-1231. PubMed ID: 29409122
[TBL] [Abstract][Full Text] [Related]
38. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
39. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
40. Preoperative D-dimers as an independent prognostic marker in cervical carcinoma.
Luo YL; Chi PD; Zheng X; Zhang L; Wang XP; Chen H
Tumour Biol; 2015 Nov; 36(11):8903-11. PubMed ID: 26071675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]